Farmacia
Facultad
Medical University of South Carolina
Charleston, Estados UnidosPublicaciones en colaboración con investigadores/as de Medical University of South Carolina (8)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2019
-
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 121-130
-
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 131-138
-
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections
Clinical Infectious Diseases, Vol. 69, Núm. 10, pp. 1812-1816
2018
-
Defining antimicrobial resistance in cystic fibrosis
Journal of Cystic Fibrosis, Vol. 17, Núm. 6, pp. 696-704
2016
-
BK channel regulation by phosphodiesterase type 1: A novel signaling pathway controlling human detrusor smooth muscle function
American Journal of Physiology - Renal Physiology, Vol. 310, Núm. 10, pp. F994-F999
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222